In this special meeting edition of the Cardiocast, MDedge Cardiology editor Catherine Hackett is joined by MDedge reporters Mitchel L. Zoler, Bruce Jancin, and Richard Mark Kirkner.
The MDedge cardiology team reviews three big stories from the 2019 annual scientific sessions of the American Heart Association in Philadelphia.
* * *
Help us make this podcast better! Please take this short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
ISCHEMIA trial hailed as practice changing
The results of the ISCHEMIA trial were emphatically declared practice changing by interventional cardiologists and noninterventionalists alike at the AHA meeting.
Bruce Jancin discusses the story.
DAPA-HF: Dapagliflozin's HFrRF efficacy confirmed in nondiabetes
The results in nondiabetics from the practice-changing DAPA-HF trial gives clinicians strong evidence that the diabetes drug dapagliflozin is equally effective at reducing cardiovascular death and acute exacerbations in heart failure patients regardless of diabetes status.
Mitchel L. Zoler discusses this report.
Weakness exposed in valsartan recall
ED visits for hypertension in the month after the 2018 recall spiked 55%. The 2018 recall of generic forms of the antihypertensive drug valsartan exposed weaknesses in the recall systems for generics in both the U.S. and Canada that caused many patients who were on the drug to fall through the cracks.
Richard Mark Kirkner goes deeper into this story.
* * *
For full coverage of AHA 2019 visit MDedge Cardiology
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeCardio
AHA 2018: Part II
AHA 2018: Part I
Bradycardia guidelines, hypertension's risk in young adults, and more
A new MI risk factor emerges, ASCVD guidelines challenged, and more
Post-MI stroke risk window expands, FFR goes wire-free, and more
CABG vs PCI, new index enhances cardiac CT, and more
NSAIDs' short-term safety, IVUS beats angio, and more
Metabolic swings predict death, hold the antiplatelet, and more
Top news from TCT, anticoagulation guidelines, and more
ESC 2018: Part II
CTA radiation, endocarditis breakthrough, ART dangers, and statins
New MI definition from ESC 2018
ESC 2018
Breastfeeding linked with lower risk of stroke later in life
New guidelines remap adult congenital heart disease
The relationship between malpractice suits and defensive medicine
More female authors than ever in cardiology journals
Blood pressure control prevents cognitive impairment
Analysis shows 'Devil's bargain' in cardiac arrest
DOACs found safer than warfarin in the real world
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive